FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis
Author(s) -
ChengHsiang Kuo,
Meng-Chen Sung,
Po-Ku Chen,
Bi-Ing Chang,
Fang-Tzu Lee,
Chia-Fong Cho,
Tai-Tzu Hsieh,
Yu-Ching Huang,
Yi-Heng Li,
Guey-Yueh Shi,
Chwan-Yau Luo,
HuaLin Wu
Publication year - 2014
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvu239
Subject(s) - angiogenesis , fibroblast growth factor receptor 1 , microbiology and biotechnology , thrombomodulin , fibroblast growth factor , biology , cancer research , chemistry , biochemistry , receptor , immunology , thrombin , platelet
The recombinant epidermal growth factor-like domain plus the serine/threonine-rich domain of thrombomodulin (rTMD23) promotes angiogenesis and accelerates the generation of activated protein C (APC), which facilitates angiogenesis. The aim of this study was to elucidate the molecular mechanisms underlying the angiogenic activity of rTMD23.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom